Dr. Leslie B Mudd is a pharmacist who is specialized in Oncology in Louisville, Kentucky. Patients can reach her at 530 S Jackson St, Louisville or contact her on 502-561-7423. Active license number of Dr. Leslie B Mudd is 7566 for Oncology in Kentucky. Dr. Leslie B Mudd is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Leslie B Mudd speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Leslie B Mudd
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
530 S Jackson St, Louisville, Kentucky, 40202-1675
Phone:
502-561-7423
Fax:
502-561-7385
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Leslie B Mudd are as mentioned below.
NPI Number:
1144308404
NPI Enumeration Date:
02 Nov, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Leslie B Mudd are as mentioned below.
Specialization
License Number
State
Status
Oncology
7566
Kentucky
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1822 Boone Trl, Louisville, Kentucky
Zip:
40245-4402
Phone Number:
502-561-7423
Fax Number:
502-561-7385
Patients can reach Dr. Leslie B Mudd at 530 S Jackson St, Louisville, Kentucky or can call on phone at 502-561-7423.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.